| A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis (NCT07479615) | Shanghai Mabgeek Biotech.Co.Ltd | 2026-05-01 |
| A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis (NCT07540442) | Shanghai Mabgeek Biotech.Co.Ltd | 2026-04-17 |
| A Study of MG-K10 in Chronic Spontaneous Urticaria (NCT07546487) | Shanghai Mabgeek Biotech.Co.Ltd | 2026-04-14 |
| A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis (NCT07103174) | Shanghai Mabgeek Biotech.Co.Ltd | 2025-06-30 |
| Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects (NCT07054034) | Shanghai Mabgeek Biotech.Co.Ltd | 2025-05-11 |
| Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma (NCT06837922) | Shanghai Mabgeek Biotech.Co.Ltd | 2025-03-25 |
| Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis (NCT06846385) | Shanghai Mabgeek Biotech.Co.Ltd | 2025-03-20 |
| Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis (NCT06779136) | Shanghai Mabgeek Biotech.Co.Ltd | 2025-02-26 |
| IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients (NCT06765005) | Shanghai Mabgeek Biotech.Co.Ltd | 2024-07-19 |
| Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis (NCT06026891) | Shanghai Mabgeek Biotech.Co.Ltd | 2024-01-13 |
| Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Healthy Adult Subjects (NCT06277284) | Shanghai Mabgeek Biotech.Co.Ltd | 2023-10-23 |
| Single Dose Clinical Trial of MG-ZG122 in Chinese Healthy Adult Subjects (NCT05659927) | Shanghai Mabgeek Biotech.Co.Ltd | 2023-02-09 |
| A Study of MG-K10 in Subjects With Asthma (NCT05382910) | Shanghai Mabgeek Biotech.Co.Ltd | 2022-07-05 |